Brussels-based MAASH secures €12.15 million to take mycoprotein production to industrial scale
MAASH, a Brussels-based fermentation company specialising in the development and production of mycoproteins for the food industry, has secured a €12.15 million funding package combining equity investment and public financing.…
Executive Summary
Real-time Market IntelligenceMAASH, a Brussels-based fermentation company specialising in the development and production of mycoproteins for the food industry, has secured a €12.15 million funding package combining equity investment and public financing.
MAASH, a Brussels-based fermentation company specialising in the development and production of mycoproteins for the food industry, has secured a €12.15 million funding package combining equity investment and public financing. The package includes a €5.85 million equity raise from five new giving MAASH the industrial, human and commercial capabilities it needs to scale.” The funding will support the launch of MAASH’s 12 m³ demonstration plant in Carling-Saint-Avold, France, and prepare the company for further scale-up to 10,000 tons of annual industrial production. The post Brussels-based MAASH secures €12.15 million to take mycoprotein production to industrial scale appeared first on EU-Startups.